Secukinumab
Brand: Cosentyx
Class: Immunomodulator
Subclass: IL-17A monoclonal antibody
PK:
t½ 27 days | Clearance: reticuloendothelial
Max Dose: not added
moderate
AE: Infections (URTI common), Candida infections, neutropenia, inflammatory bowel disease flare